These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9446497)

  • 1. With new diet drug, challenge is weighing patient demand and potential benefit.
    Jones L
    Ann Intern Med; 1996 Aug; 125(4):I58. PubMed ID: 9446497
    [No Abstract]   [Full Text] [Related]  

  • 2. Dexfenfluramine, fenfluramine, and phentermine for the treatment of morbid obesity.
    Torretta LK
    J Am Acad Nurse Pract; 1997 Aug; 9(8):389-94, quiz 395-7. PubMed ID: 9325813
    [No Abstract]   [Full Text] [Related]  

  • 3. Weighing benefits and risks of drug to treat obesity.
    Sukkari SR
    CMAJ; 1997 Mar; 156(6):768-9. PubMed ID: 9084379
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged use of a very low calorie diet (Cambridge diet) in massively obese patients attending an obesity clinic: safety, efficacy and additional benefit from dexfenfluramine.
    Finer N; Finer S; Naoumova RP
    Int J Obes; 1989; 13 Suppl 2():91-3. PubMed ID: 2613434
    [No Abstract]   [Full Text] [Related]  

  • 5. Debate over dexfenfluramine.
    Deitel M
    CMAJ; 1997 Jul; 157(1):14, 16. PubMed ID: 9220935
    [No Abstract]   [Full Text] [Related]  

  • 6. After fen-phen.
    Cowley G; Springen K
    Newsweek; 1997 Sep; 130(13):46-8. PubMed ID: 10173270
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacotherapy for obesity -- do the benefits outweigh the risks?
    Manson JE; Faich GA
    N Engl J Med; 1996 Aug; 335(9):659-60. PubMed ID: 8687523
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacological treatment of obesity. Drugs with predominantly anorectic action].
    Ortensio A; Avagnina S; Costantino A
    Minerva Dietol Gastroenterol; 1988; 34(2):109-16. PubMed ID: 3050610
    [No Abstract]   [Full Text] [Related]  

  • 9. A close look at fenfluramine and dexfenfluramine.
    Vivero LE; Anderson PO; Clark RF
    J Emerg Med; 1998; 16(2):197-205. PubMed ID: 9543401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity, dexfenfluramine, and pulmonary hypertension. A lesson not learned?
    Voelkel NF; Clarke WR; Higenbottam T
    Am J Respir Crit Care Med; 1997 Mar; 155(3):786-8. PubMed ID: 9117009
    [No Abstract]   [Full Text] [Related]  

  • 11. [Experience with the appetite depressant, fenfluramine hydrochloride, in adiposity].
    Liebermeister H; Probst G; Jahnke K
    Med Klin; 1969; 64(26):1201-7. PubMed ID: 5807324
    [No Abstract]   [Full Text] [Related]  

  • 12. To the Editor: Fenfluramine (Poderax) for obesity.
    Jackson WP
    S Afr Med J; 1969 Sep; 43(39):1207. PubMed ID: 5353789
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of a new anorectic agent AN 448 with fenfluramine in the treatment of refractory obesity.
    Goldrick RB; Nestel PJ; Havenstein N
    Med J Aust; 1974 Jun; 1(22):882-5. PubMed ID: 4604249
    [No Abstract]   [Full Text] [Related]  

  • 14. Fluoxetine is a safer alternative to fenfluramine in the medical treatment of obesity.
    Anchors M
    Arch Intern Med; 1997 Jun; 157(11):1270. PubMed ID: 9183245
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of anorexigenics in the treatment of obesity].
    Laroche C; Boissonnas A
    Therapie; 1979; 34(2):181-95. PubMed ID: 386556
    [No Abstract]   [Full Text] [Related]  

  • 16. From the Food and Drug Administration.
    Nightingale SL
    JAMA; 1996 Jul; 276(1):14. PubMed ID: 8667525
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of obesity. A call for prudence and professionalism.
    Kushner R
    Arch Intern Med; 1997 Mar; 157(6):602-4. PubMed ID: 9080914
    [No Abstract]   [Full Text] [Related]  

  • 18. New treatment for obesity: dexfenfluramine (Redux).
    Bihm B
    Medsurg Nurs; 1996 Oct; 5(5):360-2, 373. PubMed ID: 8981871
    [No Abstract]   [Full Text] [Related]  

  • 19. Iowa patients want new anti-obesity drug.
    Belling W
    Iowa Med; 1996 Sep; 86(7):278-9. PubMed ID: 8854575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypotensive effect of fenfluramine in the treatment of obesity.
    Practitioner; 1971 Jul; 207(237):101-5. PubMed ID: 5557039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.